...
首页> 外文期刊>Journal of cardiac failure >Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits.
【24h】

Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits.

机译:肾上腺素诱发的心肌病模型在充血性心力衰竭过程中的血流动力学变化和神经体液调节。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The present study was designed to study the progression of heart failure in rabbits with catecholamine-induced cardiomyopathy. METHODS AND RESULTS: We investigated the effects of three repetitive applications (at 16-day intervals) of high-dose epinephrine (first infusion, 5 micrograms/kg/min for 60 minutes; second and third infusions, 4 micrograms/kg/min for 60 minutes) on hemodynamics, echocardiographic parameters, and plasma hormone levels in eight conscious rabbits chronically instrumented with a Doppler flow probe around the proximal abdominal aorta and a catheter in the right atrium. Mean arterial pressure and blood flow velocity, as well as the acceleration of blood flow velocity (df/dt) in the proximal abdominal aorta were progressively reduced, and right atrial pressure was significantly elevated. On echocardiography, progressive left ventricular (LV) dilatation with depressed LV systolic function and an increase in LV mass were observed. Plasma atrial natriuretic peptide level was enhanced approximately fourfold after each epinephrine infusion, with a tendency to return to baseline values. Plasma renin activity (PRA) was increased after the first epinephrine application (3.0 +/- 0.5 to 6.4 +/- 0.9 ng angiotensin I (AI)/mL/h; P < .05), followed by a return to control levels. After the second epinephrine infusion, a significant decrease to 1.0 +/- 0.3 ng AI/mL/h (P < .05) was observed. After the third catecholamine treatment, PRA levels insignificantly increased. Plasma vasopressin level significantly increased from 0.5 +/- 0.2 to 1.1 +/- 0.5 pg/mL (P < .05) after the second epinephrine infusion. CONCLUSION: Repetitive infusions of high doses of epinephrine induce a cardiomyopathy with progressive hemodynamic deterioration, LV dilatation and hypertrophy, depressed systolic function, and different stages of neurohumoral compensation. This model appears to be suitable to study the progression of chronic heart failure by serial measurements in a small animal preparation.
机译:背景:本研究旨在研究儿茶酚胺诱发的心肌病兔心衰的进展。方法和结果:我们研究了大剂量肾上腺素的三种重复应用(间隔16天)的效果(第一次输注5毫克/千克/分钟,持续60分钟;第二和第三次输注4毫克/千克/分钟,对肾上腺素的影响)。 60分钟),研究了八只清醒兔子的血液动力学,超声心动图参数和血浆激素水平,这些兔子长期用多普勒血流探头绕着腹主动脉近端并在右心房置入导管。平均动脉压和血流速度以及近端腹主动脉中血流速度的加速度(df / dt)逐渐降低,而右心房压力显着升高。在超声心动图上,观察到进行性左心室(LV)扩张伴左室收缩功能降低和左室重量增加。每次肾上腺素输注后,血浆心钠素水平升高约四倍,有回到基线值的趋势。首次肾上腺素应用后,血浆肾素活性(PRA)升高(3.0 +/- 0.5至6.4 +/- 0.9 ng血管紧张素I(AI)/ mL / h; P <.05),然后恢复至对照水平。第二次肾上腺素输注后,观察到显着降低至1.0 +/- 0.3 ng AI / mL / h(P <.05)。在第三次儿茶酚胺治疗后,PRA水平无明显增加。第二次肾上腺素输注后,血浆加压素水平从0.5 +/- 0.2 pg / mL显着增加到1.1 +/- 0.5 pg / mL(P <.05)。结论:反复输注大剂量肾上腺素可导致心肌病,其进行性血流动力学恶化,左室扩张和肥大,收缩功能下降以及神经体液补偿的不同阶段。该模型似乎适合通过小型动物制剂中的系列测量研究慢性心力衰竭的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号